-

Dante Omics Awarded Prestigious ISO 9001 Certification for Italian Laboratory

Leading Genomics AI Company Reaches New Milestone in Quality Management and Operational Excellence at its Italian laboratory Dante Labs

NEW YORK--(BUSINESS WIRE)--Dante Omics, a trailblazer in genomics-driven artificial intelligence solutions, is proud to announce that its cutting-edge laboratory in Italy has been awarded the internationally recognized ISO 9001:2015 certification for “Provision of genomic Next Generation Sequencing, analysis and interpretation services.” The ISO9001 certification was issued to Dante Labs Srl. This achievement marks a significant step in the company’s commitment to maintaining the highest standards in quality management, ensuring the delivery of innovative and reliable genomic solutions to its global clients.

The ISO 9001 certification, the world's most widely recognized quality management standard, was awarded following a rigorous audit of Dante Omics' operational processes, quality control systems, and customer service protocols. This certification underlines the company’s dedication to continuous improvement and its strategic focus on delivering excellence in genomic data analysis, precision medicine, and AI-powered solutions.

“We are thrilled to receive the ISO 9001 certification for our Italian laboratory,” said Andrea Riposati, CEO of Dante Omics. “This milestone is a testament to our team's hard work and commitment to providing the highest quality genomics services. It reflects our ongoing efforts to refine our operations and offer our clients the most advanced, reliable, and efficient genomic solutions in the industry.”

The certified Italian lab plays a pivotal role in Dante Omics’ research and development efforts, focusing on leveraging AI to advance genomics-based diagnostics, personalized medicine, and therapeutic innovations. This certification assures clients that the company’s systems and processes meet strict international standards for consistency, quality, and continuous improvement.

Dante Omics plans to build on this achievement by further expanding its research capabilities and enhancing its AI-driven genomics solutions. With the ISO 9001 certification, the company is well-positioned to continue its mission of revolutionizing healthcare through the power of genomics and artificial intelligence.

Contacts

Laura Rossi
media@dantelabs.com
+39 0862 191 0671

Dante Omics

Details
Headquarters: New York, USA
CEO: Andrea Riposati
Employees: 42
Organization: PRI

Release Versions

Contacts

Laura Rossi
media@dantelabs.com
+39 0862 191 0671

Social Media Profiles
More News From Dante Omics

Trieste, L'Aquila, Rome: the Italian genomics triangle assembles the new diploid RPE-1 genome, the missing piece for CRISPR, immediately published in California and on Nature magazine – with Dante Labs, Area Science Park, and La Sapienza University

ROME--(BUSINESS WIRE)--A few weeks ago, the USCS Genome Browser at the University of California, Santa Cruz, the bible of reference genomics, published a new and very important reference genome, Diploid RPE-1, key to the study of centromeres, thanks to the work of the Area Science Park in Trieste, the Giunta Lab at Sapienza University, Dante Labs, and the University of L'Aquila. These innovative Italian institutions have formed an international alliance with Rockefeller University in New York a...

From Blurry to 4K DNA: Dante Omics AI, Rockefeller University, Giunta Lab and Global Partners Assemble the Most Complete Genome for the RPE-1 Cell Line – the Standard for Complex Cell Engineering Experiments

NEW YORK--(BUSINESS WIRE)--Dante Omics AI, Rockefeller University, Giunta Lab, Sapienza University, University of Tennessee, Trieste Area Science Park and University of L’Aquila published the successful assembly of a near-complete human diploid reference genome for one of the world’s most widely used cell lines. This breakthrough provides a reference-quality blueprint of the RPE-1 cell line, a workhorse in laboratories around the globe. Dante Omics leveraged its expertise with the Dante Labs ge...

Dante Omics AI Ushers Genomics Into the AI Age With GPU-Accelerated Proprietary Multiomics Platform

NEW YORK--(BUSINESS WIRE)--Dante Omics AI, a pioneering force in computational genomics, today announced a groundbreaking upgrade to its proprietary genome and multiomics alignment, variant calling and reporting platform. The enhanced system leverages cutting-edge NVIDIA GPU technology to deliver unprecedented speed and accuracy in genomic analysis, marking a transformative leap forward in bringing genomics fully into the artificial intelligence age. Revolutionary GPU-Accelerated Genomics Pipel...
Back to Newsroom